Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > DSU's to Franzi

<< Previous

Bullboard Posts

Next >>

Comment by gebremeskelon Aug 20, 2024 3:46pm

177 Views

Post# 36188576

RE:DSU's to Franzi

I wouldn't be surprised to hear Mr. Franzi is front and centre in the negotiations between Spectral Medical and the Carlyle Group. The success of these negotiations could mean the end of Spectral Medical as a separate entity so an award of DSU's would be an appropriate reward, "DSUs generally cannot be redeemed until after your retirement, termination of your employment, or death."

Accountprince wrote: Franzi (former Baxter exec) was granted 104,478 DSU's on Aug 16 and reported on Aug 19. Large initial grant to him so significant. I think this bodes well for where we're heading. Too many positives to ignore. Wishing all the real shareholders here the best!

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale